Affiliation:
1. The Second Affiliated Hospital of Wannan Medical College
2. The First Affiliated Hospital of Wannan Medical College
Abstract
AbstractIt is crucial to probe into the biological effect and mechanism of miRNA-485-5p regulating KRT17 in pancreatic cancer (PC) to understand its pathogenesis and identify potential biological targets. The bioinformatics means were used to evaluate the clinical significance of KRT17 expression in the TCGA database. TargetScan database analysis in conjunction with dual luciferase and RNA Immunoprecipitation (RIP) experiments was used to probe the interaction relationship of miRNA-485-5p with KRT17. The expression of miRNA-485-5p and KRT17 in PC tissue and cancer cell lines was detected by Q-PCR paired with western blot assay. The biological function of miRNA-485-5p in regulating KRT17 was investigated in the PC cell line via gene silencing/overexpression technique. A western blot experiment was utilized to investigate the regulatory effect of KRT17 on cell cycle-related proteins and the FAK/Src/ERK signal pathway. The level of KRT17 was dramatically increased in PC tissues and this significantly decreased the survival rate of PC patients. TargetScan in combination with dual luciferase and RIP experiments verified the miRNA-485-5p target KRT17. The expression of KRT17 was high in the PC cell line, although the expression of miRNA-485-5p was low. Silencing KRT17 or overexpression of miRNA-485-5p significantly inhibited PC cell viability, proliferation, invasion, and colony formation, while promoting apoptosis. In contrast, overexpression of KRT17 drastically reversed the function of miRNA-485-5p. The silenced KRT17 remarkably downregulated the expression of cyclinD1, CDK1, CDK2, p-FAK, p-Src, and p-ERK proteins in the PC cells. Generally, an essential signaling cascade of miRNA-485-5p/KRT17/FAK/Src/ERK influences the biological functions of PC cells.
Publisher
Research Square Platform LLC
Reference50 articles.
1. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors;Klein AP;Nature reviews. Gastroenterology & hepatology
2. M. A. Tempero, “NCCN Guidelines Updates: Pancreatic Cancer,” Journal of the National Comprehensive Cancer Network: JNCCN, vol. 17, no. 5.5, pp. 603–605, 2019/5/1/.
3. Immunotherapy for pancreatic cancer: A 2020 update;Schizas D;Cancer treatment reviews
4. Therapeutic developments in pancreatic cancer: current and future perspectives;Neoptolemos JP;Nature reviews. Gastroenterology & hepatology
5. Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits;Heinrich S;International journal of molecular sciences